Review article · 2020 · Open access

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

Cristina d’Abramo, Luciano D'adamio, Luca Giliberto

Journal of Personalized Medicine, 10(3), 116 · Published 8 September 2020 · DOI 10.3390/jpm10030116

Open full textCite this paper

In brief

“Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use” is a 2020 review article by Cristina d’Abramo and 2 co-authors, published in Journal of Personalized Medicine. OpenAlex counts 78 citations as of 19 November 2026, which puts it in the top 4% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Personalized Medicine.

Citations
78
Most cited in
2025 (18)
Field-weighted impact
1.06
References
358
Authors
3

Abstract

Alzheimer's disease (AD) is the most common type of dementia, affecting more than 5 million Americans, with steadily increasing mortality and incredible socio-economic burden. Not only have therapeutic efforts so far failed to reach significant efficacy, but the real pathogenesis of the disease is still obscure. The current theories are based on pathological findings of amyloid plaques and tau neurofibrillary tangles that accumulate in the brain parenchyma of affected patients. These findings have defined, together with the extensive neurodegeneration, the diagnostic criteria of the disease. The ability to detect changes in the levels of amyloid and tau in cerebrospinal fluid (CSF) first, and more recently in blood, has allowed us to use these biomarkers for the specific in-vivo diagnosis of AD in humans. Furthermore, other pathological elements of AD, such as the loss of neurons, inflammation and metabolic derangement, have translated to the definition of other CSF and blood biomarkers, which are not specific of the disease but, when combined with amyloid and tau, correlate with the progression from mild cognitive impairment to AD dementia, or identify patients who will develop AD pathology. In this review, we discuss the role of current and hypothetical biomarkers of Alzheimer's disease, their specificity, and the caveats of current high-sensitivity platforms for their peripheral detection.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

d’Abramo, C., D'adamio, L., & Giliberto, L. (2020). Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use. Journal of Personalized Medicine, 10(3), 116. https://doi.org/10.3390/jpm10030116

MLA 9

d’Abramo, Cristina, et al. “Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use.” Journal of Personalized Medicine, vol. 10, no. 3, 2020, p. 116. https://doi.org/10.3390/jpm10030116.

Chicago

d’Abramo, Cristina, Luciano D'adamio, and Luca Giliberto. 2020. “Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use.” Journal of Personalized Medicine 10 (3): 116. https://doi.org/10.3390/jpm10030116.

Harvard

d’Abramo, C., D'adamio, L. and Giliberto, L. (2020) ‘Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use’, Journal of Personalized Medicine, 10(3), p. 116. doi:10.3390/jpm10030116.

IEEE

C. d’Abramo, L. D'adamio, and L. Giliberto, “Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use,” Journal of Personalized Medicine, vol. 10, no. 3, p. 116, 2020, doi: 10.3390/jpm10030116.

BibTeX

@article{dabramo2020significance,
  title     = {{Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use}},
  author    = {d’Abramo, Cristina and D'adamio, Luciano and Giliberto, Luca},
  journal   = {Journal of Personalized Medicine},
  year      = {2020},
  volume    = {10},
  number    = {3},
  pages     = {116},
  doi       = {10.3390/jpm10030116},
  url       = {https://doi.org/10.3390/jpm10030116}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202044
20211212
202299
202388
20241616
20251818
20261111

Its field-weighted citation impact is 1.06: it has been cited 1.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • blood biomarkers
  • cerebrospinal fluid biomarkers
  • amyloid
  • tau protein
  • sensitivity and specificity
  • mild cognitive impairment
  • neuroinflammation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

d’Abramo, C., D'adamio, L., & Giliberto, L. (2020). Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use. Journal of Personalized Medicine, 10(3), 116. https://doi.org/10.3390/jpm10030116

How many times has this paper been cited?

78 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Personalized Medicine: sign in and open the full text from this page.

Who wrote this paper?

Cristina d’Abramo, Luciano D'adamio, Luca Giliberto.

What is the DOI of this paper?

10.3390/jpm10030116, permanently at https://doi.org/10.3390/jpm10030116. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.